Vacuum Erection Devices
Osbon ErecAid, Encore, Pos-T-Vac, Timm Osbon (VED / vacuum pumps)
Evidence grade 4 of 5, Strong. Read how the Atlas grades evidence.
The written rationale for this grade is still being prepared.
- FDA
- FDA cleared (device class; available OTC and by prescription)
Reference only. Not medical advice.
What can go wrong
Generally very safe. Because the ring occludes flow at the base only, the erection hinges (pivots) at the base and the shaft beyond the ring can feel cool to the touch, the classic 'cold, hinged erection' limitation. Other effects include bruising, petechiae, numbness, trapped ejaculation, and discomfort. The constriction ring should not be left on longer than about 30 minutes to avoid ischemic tissue injury; men on blood thinners or with bleeding disorders need caution.
This is something to take to a clinician. The Atlas can tell you what is known about vacuum erection devices in general. It cannot tell you what is happening in your body, and the difference matters most for exactly the symptoms that bring people to this page.
A vacuum erection device (VED) is a plastic cylinder placed over the penis; a hand or battery pump creates negative pressure that draws blood into the corpora, and a constriction ring slid onto the base traps the blood to sustain the erection. Established brands include the Osbon ErecAid (the pioneering brand, later Timm Osbon), Encore, Pos-T-Vac, and Vacurect. VEDs are non-pharmacologic, reusable, and widely used both for on-demand erections and for penile rehabilitation after prostatectomy.
Draw blood in with a vacuum, trap it with a ring.
What people take it for
What it is taken for. Approval, where it exists, covers only some of these.
How it works
Negative pressure in the cylinder pulls venous and arterial blood into the penile shaft, producing engorgement independent of arousal or nerve/vascular function. A silicone tension ring transferred to the base of the penis occludes venous outflow to maintain rigidity for intercourse; the ring is removed after use.
What people get wrong
Often saidA vacuum pump permanently enlarges the penis
ActuallyVEDs produce a temporary erection for intercourse (and are used in rehabilitation); marketing claims of permanent enlargement from pumping are not supported by evidence.
Who profits, and who pushes back
Nobody is named here yet, because we have not done that work on this entry. Read that as unfinished. Somebody almost certainly sells this, and somebody almost certainly disputes it. Assume both until we have checked.
Set against the alternatives
VEDs work regardless of the vascular or neural cause of ED and avoid systemic drug effects, an advantage over pills. The trade-off is the mechanical process, the hinged/cool erection, and lower long-term adherence. Combining a VED with a PDE5 inhibitor can push success rates past 90% in some studies.
Legal status
Available over the counter and by prescription; medical-grade devices include a pressure-limiting mechanism that cheap novelty pumps lack.
Status current as of July 2026. Regulatory positions change, sometimes quickly.
The market for this
What follows describes how this is bought and sold. It is not a buying guide and it is not an endorsement of any seller.
A one-time purchase, often $100-$500 for a medical-grade device, sometimes covered by Medicare/insurance with a prescription, making it among the cheaper durable ED treatments over time.
At a glance
- Mechanism
- Negative-pressure cylinder + constriction ring
- Efficacy
- ~71% to mid-80s in RCTs; 80-90% satisfaction in selected series
- Ring rule
- Remove within 30 minutes
- Pioneer brand
- Osbon ErecAid (Timm Osbon)
What this entry does not yet cover
What follows is unfinished work on our side, not a finding about Vacuum Erection Devices. A short entry is not a safe entry.
- Timeline. We have not built the dated record of research and regulatory events.
- Supply chain. We have not mapped where it is made.
- Who uses it. We have not documented the user groups.
- What could change. No forward-looking summary yet.
- Children and teenagers. We have not checked what is known about younger people.
- Where we land. We have not taken a position on this yet.
Sources
The studies below are named and described, but not linked. You cannot open them from here and check our reading against them, which means this page is our summary of the literature rather than a document you can verify. Weigh it accordingly until the links exist.
The studies that matter
RCTs and systematic reviews of VED efficacyreported
Efficacy roughly 71% to mid-80s; 80-90% satisfaction in selected cohorts
5th International Consultation on Sexual Medicine VED recommendations2024
Reviewed VED efficacy and role, including post-prostatectomy rehabilitation
Long-term continuation datareported
High initial success but discontinuation up to ~65% in some cohorts, driven by inconvenience and the unnatural erection